Bulk Drugs

Challenges faced by bulk drug manufacturers in India

India produces over 1/5th of bulk drug production in the world. However, the bulk drugs manufacturers are facing regulatory hurdles in many area. Currently, irrespective of pollution load, change in product mix have to be notified with Ministry of Environment and has to be approved by them. There are many cases, where there may be drop in pollution load because of change in product mix, but the company has to spend over 6 months to get approval. Besides, the effluent treated out of the company has to be mandatoriy treated again in Common Effluent Treatment plants of same standard. This increases cost and capital expenditure. In global export scenario, Chinese are proactive to tweak regulation to suit their interest, while India takes more time. No wonder, we import more than 60% of our bu
Read More

Enal Drugs plans expansion programme at Wangapally

Enal Drugs is planning an expansion programme of its plant in Wangapally in Yadagirigutta in Nalagonda district of Telangana. The project involves expanding manufacturing capacity of active pharmaceutical ingredients from 966 tpa to 1800 tpa. The project cost is estimated at Rs. 400 million. After expansion, the plant will produce Lansoprazole, Rabeprazole Sodium, Zalepon, Omeprazole and other anti ulcerative drug intermediates.
Read More

Telangana to unveil new Pharma policy

Telangana government is ready to unveil a draft new policy on Pharma and Bulk Drug Sector. The state government has acquired 11,000 acres of land at Mucherla at the outskirts of Hyderabad . (roughly 70 kms away ) They are in the process of preparing a detailed project report (DPR) in coordination with the pharma industry and the pollution control board so that every ingredient required for the industry and environment safety is incorporated. With the ?Make in India policy? of the government, the industry is expecting sops like tax breaks, weighted tax deduction at 150 per cent for R&D expenditure and availability of affordable land for the industry. Already, Hyderabad has a strong base for bulk drug industries in India contributing one third of country?s bulk drug production. Taking t
Read More


  • No Image
    Amsal Chem Pvt Ltd

    Amsal Chem incorporated in 1992 is a bulk drug manufacturer with two chief products: isoniazid and niacin/niacinamide. The company is promoted by the Majithia family, with its m

  • No Image
    Amsar Pvt Ltd

    Amsar was founded by two scientists with Post Graduate degrees in chemistry from England and Doctoral degrees from Switzerland

  • No Image
    Amzole India Pvt Ltd

    Amzole India was established in 1987 was originally a manufacturer of 2-Methyl Imidazole (CAS No. 693-98-1). However, due to strategic reasons, in late 1988 the plant process wa

  • No Image
    Andhra Organics Ltd

    Andhra Organics Ltd is a subsidiary of Virchow Laboratories Ltd . It was promoted by Dr. N Venkata Reddy, Mr. M Narayana Reddy, Mr. L V Subba Reddy, and Mr. Ravindra Reddy, and